Peptide-based Tolerance

Peptide-Based Tolerance is a therapeutic strategy within immune tolerance induction that employs specific antigenic peptides to selectively modulate T-cell responses, thereby promoting immune unresponsiveness to particular self- or foreign antigens while preserving overall immune competence.

61

Publications

5K

Citations

391

Authors

161

Institutions

Publications per year

2017–2026

4

Authors

391

  1. BH
    Bevra H. Hahn

    University of California, Los Angeles, United States

    5 publications · 458 citations

    5

    h-index

  2. AL
    Antonio La Cava

    University of California, Los Angeles, United States

    4 publications · 349 citations

    4

    h-index

  3. FM
    Fanny M. Ebling

    University of California, Los Angeles, United States

    4 publications · 442 citations

    4

    h-index

  4. SD
    Stephen D. Miller

    Northwestern University, United States

    3 publications · 713 citations

    3

    h-index

  5. DW
    David W. Scott

    Duke University, United States

    3 publications · 161 citations

    3

    h-index

1–5 of 391

Venues

  1. The Journal of Immunology

    JI · 20 publications · 1.3K citations

    17

    h-index

  2. Transplantation

    4 publications · 145 citations

    4

    h-index

  3. European Journal of Immunology

    EJI · 4 publications · 147 citations

    4

    h-index

  4. Proceedings of the National Academy of Sciences

    PNAS · 3 publications · 171 citations

    3

    h-index

  5. Arthritis & Rheumatism

    2 publications · 255 citations

    2

    h-index

1–5